CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 140 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2016. The put-call ratio across all filers is 1.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $7,682,000 | +9.6% | 67,922 | -3.0% | 2.10% | +20.5% |
| Q1 2017 | $7,012,000 | -28.1% | 70,032 | -22.8% | 1.74% | -24.3% |
| Q4 2016 | $9,757,000 | -16.4% | 90,748 | -3.2% | 2.30% | -14.7% |
| Q3 2016 | $11,674,000 | +16.7% | 93,784 | -0.3% | 2.70% | +10.6% |
| Q2 2016 | $10,002,000 | +2.0% | 94,074 | +9.9% | 2.44% | -8.3% |
| Q1 2016 | $9,802,000 | -30.1% | 85,623 | -13.0% | 2.66% | -24.3% |
| Q4 2015 | $14,028,000 | +31.3% | 98,470 | +5.3% | 3.51% | +23.6% |
| Q3 2015 | $10,681,000 | +47.2% | 93,479 | +58.2% | 2.84% | +11.2% |
| Q2 2015 | $7,258,000 | +27.1% | 59,101 | -1.2% | 2.56% | +14.3% |
| Q1 2015 | $5,710,000 | +280.9% | 59,789 | +168.1% | 2.24% | +263.6% |
| Q4 2014 | $1,499,000 | +31.7% | 22,299 | +5.7% | 0.62% | +37.0% |
| Q3 2014 | $1,138,000 | +29.2% | 21,093 | +6.4% | 0.45% | +17.8% |
| Q2 2014 | $881,000 | +7.4% | 19,819 | -16.0% | 0.38% | +14.4% |
| Q1 2014 | $820,000 | +5.1% | 23,600 | -12.7% | 0.33% | -2.6% |
| Q4 2013 | $780,000 | +17.5% | 27,040 | +18.9% | 0.34% | +8.6% |
| Q3 2013 | $664,000 | – | 22,746 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 8,344,200 | $960,918,000 | 7.67% |
| RUDMAN ERROL M | 130,201 | $14,994,000 | 5.06% |
| Ativo Capital Management LLC | 59,101 | $7,258,000 | 2.56% |
| Kylin Management | 188,226 | $21,676,000 | 2.36% |
| Monashee Investment Management LLC | 40,000 | $4,606,000 | 2.17% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 62,866 | $7,240,000 | 1.91% |
| Cormorant Asset Management, LP | 111,500 | $12,840,000 | 1.71% |
| OBERWEIS ASSET MANAGEMENT INC/ | 53,500 | $6,161,000 | 1.63% |
| Perceptive Advisors | 147,604 | $16,998,000 | 1.02% |
| Granite Point Capital Management, L.P. | 29,160 | $3,358,000 | 0.98% |